Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Leukocyte surface antigen]

K Nakahara1

  • 1Department of Laboratory Medicine, Faculty of Medicine, University of Tokyo.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Immunological methods using monoclonal antibodies and flow cytometry detect cell surface antigens for diagnosing and managing leukemias. This analysis classifies lymphocyte subtypes, aiding prognosis and treatment decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson's disease].

Rinsho shinkeigaku = Clinical neurology·2000
Same author

Long-term intravenous perinatal cocaine exposure on the mortality of rat offspring.

Neurotoxicology and teratology·2000
Same author

Possible involvement of orexin in the stress reaction in rats.

Biochemical and biophysical research communications·2000
Same author

Structural analysis of the gene encoding RP58, a sequence-specific transrepressor associated with heterochromatin.

Gene·2000
Same author

A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma.

Blood·2000
Same author

Red wine polyphenols inhibit proliferation of vascular smooth muscle cells and downregulate expression of cyclin A gene.

Circulation·2000
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Context:

  • Leukemic and normal blood cells express unique cell surface antigens.
  • Immunological methods like flow cytometry are crucial in tumor research and clinical diagnostics.

Purpose:

  • To apply immunological methods for detecting cell-specific antigens on leukemic cells.
  • To utilize flow cytometry and monoclonal antibodies for enhanced diagnosis and management of hematological disorders.

Summary:

  • Analysis of cell surface markers aids in classifying lymphocyte subtypes and determining their developmental origin, especially in lymphocytic leukemias.
  • This method is routinely used in laboratories for diagnosing and managing hematological malignancies like leukemias and lymphomas.

Impact:

Related Experiment Videos

  • Provides critical information for determining clinical prognosis.
  • Guides the selection of appropriate treatment options.
  • Enables accurate judgment of treatment efficacy in hematological disorders.